CYP2E1, a cytochrome P-450 that is well conserved across mammalian species, metabolizes ethanol and many low molecular weight toxins and cancer suspect agents. The cyp2e1 gene was isolated, and a mouse line that lacks expression of CYP2E1 was generated by homologous recombination in embryonic stem cells. Animals deficient in expression of the enzyme were fertile, developed normally, and exhibited no obvious phenotypic abnormalities, thus indicating that CYP2E1 has no critical role in mammalian development and physiology in the absence of external stimuli. When cyp2e1 knockout mice were challenged with the common analgesic acetaminophen, they were found to be considerably less sensitive to its hepatotoxic effects than wild-type animals, indicating that this P-450 is the principal enzyme responsible for the metabolic conversion of the drug to its active hepatotoxic metabolite.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				P. Boadas-Vaello, E. Jover, S. Saldana-Ruiz, C. Soler-Martin, C. Chabbert, J. M. Bayona, and J. Llorens Allylnitrile Metabolism by CYP2E1 and Other CYPs Leads to Distinct Lethal and Vestibulotoxic Effects in the Mouse Toxicol. Sci., February 1, 2009; 107(2): 461 - 472. [Abstract] [Full Text] [PDF]

				M. P. Holt, L. Cheng, and C. Ju Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury J. Leukoc. Biol., December 1, 2008; 84(6): 1410 - 1421. [Abstract] [Full Text] [PDF]

				C. Cheung and F. J. Gonzalez Humanized Mouse Lines and Their Application for Prediction of Human Drug Metabolism and Toxicological Risk Assessment J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 288 - 299. [Abstract] [Full Text] [PDF]

				L. A. McLaughlin, L. J. Dickmann, C. R. Wolf, and C. J. Henderson Functional Expression and Comparative Characterization of Nine Murine Cytochromes P450 by Fluorescent Inhibition Screening Drug Metab. Dispos., July 1, 2008; 36(7): 1322 - 1331. [Abstract] [Full Text] [PDF]

				M. Dostalek, K. D. Hardy, G. L. Milne, J. D. Morrow, C. Chen, F. J. Gonzalez, J. Gu, X. Ding, D. A. Johnson, J. A. Johnson, et al. Development of Oxidative Stress by Cytochrome P450 Induction in Rodents Is Selective for Barbiturates and Related to Loss of Pyridine Nucleotide-dependent Protective Systems J. Biol. Chem., June 20, 2008; 283(25): 17147 - 17157. [Abstract] [Full Text] [PDF]

				C. Chen, K. W. Krausz, J. R. Idle, and F. J. Gonzalez Identification of Novel Toxicity-associated Metabolites by Metabolomics and Mass Isotopomer Analysis of Acetaminophen Metabolism in Wild-type and Cyp2e1-null Mice J. Biol. Chem., February 22, 2008; 283(8): 4543 - 4559. [Abstract] [Full Text] [PDF]

				J. S. Kang, H. Wanibuchi, K. Morimura, F. J. Gonzalez, and S. Fukushima Role of CYP2E1 in Diethylnitrosamine-Induced Hepatocarcinogenesis In vivo Cancer Res., December 1, 2007; 67(23): 11141 - 11146. [Abstract] [Full Text] [PDF]

				K. K. Wolf, S. G. Wood, J. L. Allard, J. A. Hunt, N. Gorman, B. W. Walton-Strong, J. G. Szakacs, S. X. Duan, Q. Hao, M. H. Court, et al. Role of CYP3A and CYP2E1 in Alcohol-Mediated Increases in Acetaminophen Hepatotoxicity: Comparison of Wild-Type and Cyp2e1(-/-) Mice Drug Metab. Dispos., July 1, 2007; 35(7): 1223 - 1231. [Abstract] [Full Text] [PDF]

				T. Ito, K. Asakura, K. Tougou, T. Fukuda, R. Kubota, S. Nonen, Y. Fujio, and J. Azuma Regulation of Cytochrome P450 2E1 under Hypertonic Environment through TonEBP in Human Hepatocytes Mol. Pharmacol., July 1, 2007; 72(1): 173 - 181. [Abstract] [Full Text] [PDF]

				C. G. Woods, J. P. Vanden Heuvel, and I. Rusyn Genomic Profiling in Nuclear Receptor-Mediated Toxicity Toxicol Pathol, June 1, 2007; 35(4): 474 - 494. [Abstract] [Full Text] [PDF]

				C. E. Garner, C. Sloan, S.C.J. Sumner, J. Burgess, J. Davis, A. Etheridge, A. Parham, and B.I. Ghanayem CYP2E1-Catalyzed Oxidation Contributes to the Sperm Toxicity of 1-Bromopropane in Mice Biol Reprod, March 1, 2007; 76(3): 496 - 505. [Abstract] [Full Text] [PDF]

				B. I. Ghanayem Inhibition of Urethane-Induced Carcinogenicity in Cyp2e1-/- in Comparison to Cyp2e1+/+ Mice Toxicol. Sci., February 1, 2007; 95(2): 331 - 339. [Abstract] [Full Text] [PDF]

				F. J. Gonzalez CYP2E1 Drug Metab. Dispos., January 1, 2007; 35(1): 1 - 8. [Abstract] [Full Text] [PDF]

				D. Kim and B. I. Ghanayem Comparative Metabolism and Disposition of Trichloroethylene in Cyp2e1-/-and Wild-Type Mice Drug Metab. Dispos., December 1, 2006; 34(12): 2020 - 2027. [Abstract] [Full Text] [PDF]

				P. Gong and A. I. Cederbaum Transcription Factor Nrf2 Protects HepG2 Cells against CYP2E1 plus Arachidonic Acid-dependent Toxicity J. Biol. Chem., May 26, 2006; 281(21): 14573 - 14579. [Abstract] [Full Text] [PDF]

				J.-H. Zhu and X. G. Lei Double Null of Selenium-Glutathione Peroxidase-1 and Copper, Zinc-Superoxide Dismutase Enhances Resistance of Mouse Primary Hepatocytes to Acetaminophen Toxicity. Experimental Biology and Medicine, May 1, 2006; 231(5): 545 - 552. [Abstract] [Full Text] [PDF]

				P.-G. Forkert, B. Millen, L. H. Lash, D. A. Putt, and B. I. Ghanayem Pulmonary Bronchiolar Cytotoxicity and Formation of Dichloroacetyl Lysine Protein Adducts in Mice Treated with Trichloroethylene J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 520 - 529. [Abstract] [Full Text] [PDF]

				K. K. Wolf, S. G. Wood, J. A. Hunt, B. W. Walton-Strong, K. Yasuda, L. Lan, S. X. Duan, Q. Hao, S. A. Wrighton, E. H. Jeffery, et al. ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY Drug Metab. Dispos., December 1, 2005; 33(12): 1827 - 1836. [Abstract] [Full Text] [PDF]

				B. I. Ghanayem, L. P. McDaniel, M. I. Churchwell, N. C. Twaddle, R. Snyder, T. R. Fennell, and D. R. Doerge Role of CYP2E1 in the Epoxidation of Acrylamide to Glycidamide and Formation of DNA and Hemoglobin Adducts Toxicol. Sci., December 1, 2005; 88(2): 311 - 318. [Abstract] [Full Text] [PDF]

				G. Dai, N. Chou, L. He, M. A. Gyamfi, A. J. Mendy, A. L. Slitt, C. D. Klaassen, and Y.-J. Y. Wan Retinoid X Receptor {alpha} Regulates the Expression of Glutathione S-transferase Genes and Modulates Acetaminophen-Glutathione Conjugation in Mouse Liver Mol. Pharmacol., December 1, 2005; 68(6): 1590 - 1596. [Abstract] [Full Text] [PDF]

				U. Hoffler and B. I. Ghanayem INCREASED BIOACCUMULATION OF URETHANE IN CYP2E1-/- VERSUS CYP2E1+/+ MICE Drug Metab. Dispos., August 1, 2005; 33(8): 1144 - 1150. [Abstract] [Full Text] [PDF]

				H. Liu and R. Baliga Endoplasmic Reticulum Stress-Associated Caspase 12 Mediates Cisplatin-Induced LLC-PK1 Cell Apoptosis J. Am. Soc. Nephrol., July 1, 2005; 16(7): 1985 - 1992. [Abstract] [Full Text] [PDF]

				C. Cheung, A.-M. Yu, J. M. Ward, K. W. Krausz, T. E. Akiyama, L. Feigenbaum, and F. J. Gonzalez THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY Drug Metab. Dispos., March 1, 2005; 33(3): 449 - 457. [Abstract] [Full Text] [PDF]

				J. Gu, H. Cui, M. Behr, L. Zhang, Q.-Y. Zhang, W. Yang, J. A. Hinson, and X. Ding In Vivo Mechanisms of Tissue-Selective Drug Toxicity: Effects of Liver-Specific Knockout of the NADPH-Cytochrome P450 Reductase Gene on Acetaminophen Toxicity in Kidney, Lung, and Nasal Mucosa Mol. Pharmacol., March 1, 2005; 67(3): 623 - 630. [Abstract] [Full Text] [PDF]

				B.I. Ghanayem, K.L. Witt, L. El-Hadri, U. Hoffler, G.E. Kissling, M.D. Shelby, and J.B. Bishop Comparison of Germ Cell Mutagenicity in Male CYP2E1-Null and Wild-Type Mice Treated with Acrylamide: Evidence Supporting a Glycidamide-Mediated Effect Biol Reprod, January 1, 2005; 72(1): 157 - 163. [Abstract] [Full Text] [PDF]

				G. L. Guo, J. S. Moffit, C. J. Nicol, J. M. Ward, L. A. Aleksunes, A. L. Slitt, S. A. Kliewer, J. E. Manautou, and F. J. Gonzalez Enhanced Acetaminophen Toxicity by Activation of the Pregnane X Receptor Toxicol. Sci., December 1, 2004; 82(2): 374 - 380. [Abstract] [Full Text] [PDF]

				A. C. Simmonds, C. A. Reilly, R. M. Baldwin, B. I. Ghanayem, D. L. Lanza, G. S. Yost, K. S. Collins, and P.-G. Forkert BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES Drug Metab. Dispos., September 1, 2004; 32(9): 1032 - 1039. [Abstract] [Full Text] [PDF]

				A. C. Simmonds, B. I. Ghanayem, A. Sharma, C. A. Reilly, B. Millen, G. S. Yost, and P.-G. Forkert Bioactivation of 1,1-Dichloroethylene by CYP2E1 and CYP2F2 in Murine Lung J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 855 - 864. [Abstract] [Full Text] [PDF]

				K. K. Wolf, S. G. Wood, J. L. Bement, P. R. Sinclair, S. A. Wrighton, E. Jeffery, F. J. Gonzalez, and J. F. Sinclair ROLE OF MOUSE CYP2E1 IN THE O-HYDROXYLATION OF P-NITROPHENOL: COMPARISON OF ACTIVITIES IN HEPATIC MICROSOMES FROM CYP2E1(-/-) AND WILD-TYPE MICE Drug Metab. Dispos., July 1, 2004; 32(7): 681 - 684. [Abstract] [Full Text] [PDF]

				J. L. Raucy, J. Lasker, K. Ozaki, and V. Zoleta Regulation of CYP2E1 by Ethanol and Palmitic Acid and CYP4A11 by Clofibrate in Primary Cultures of Human Hepatocytes Toxicol. Sci., June 1, 2004; 79(2): 233 - 241. [Abstract] [Full Text] [PDF]

				C. J. Henderson and C. R. Wolf Transgenic Analysis of Human Drug-Metabolizing Enzymes: Preclinical Drug Development and Toxicology Mol. Interv., September 1, 2003; 3(6): 331 - 343. [Abstract] [Full Text] [PDF]

				K. S. Sugamori, S. Wong, A. Gaedigk, V. Yu, H. Abramovici, R. Rozmahel, and D. M. Grant Generation and Functional Characterization of Arylamine N-Acetyltransferase Nat1/Nat2Double-Knockout Mice Mol. Pharmacol., July 1, 2003; 64(1): 170 - 179. [Abstract] [Full Text] [PDF]

				L. H. Lash, R. N. Hines, F. J. Gonzalez, T. R. Zacharewski, and M. A. Rothstein Genetics and Susceptibility to Toxic Chemicals: Do You (or Should You) Know Your Genetic Profile? J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 403 - 409. [Abstract] [Full Text] [PDF]

				U. Hoffler, H. A. El-Masri, and B. I. Ghanayem Cytochrome P450 2E1 (CYP2E1) Is the Principal Enzyme Responsible for Urethane Metabolism: Comparative Studies Using CYP2E1-Null and Wild-Type Mice J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 557 - 564. [Abstract] [Full Text] [PDF]

				C. J. Henderson, D. M. E. Otto, D. Carrie, M. A. Magnuson, A. W. McLaren, I. Rosewell, and C. R. Wolf Inactivation of the Hepatic Cytochrome P450 System by Conditional Deletion of Hepatic Cytochrome P450 Reductase J. Biol. Chem., April 4, 2003; 278(15): 13480 - 13486. [Abstract] [Full Text] [PDF]

				C. Lejus, C. Le Roux, E. Legendre, M. Renaudin, H. L. Boiteau, and M. Pinaud Fluoride excretion in children after sevoflurane anaesthesia Br. J. Anaesth., November 1, 2002; 89(5): 693 - 696. [Abstract] [Full Text] [PDF]

				H. Wang, B. Chanas, and B. I. Ghanayem Cytochrome P450 2E1 (CYP2E1) is Essential for Acrylonitrile Metabolism to Cyanide: Comparative Studies Using CYP2E1-Null and Wild-Type Mice Drug Metab. Dispos., August 1, 2002; 30(8): 911 - 917. [Abstract] [Full Text] [PDF]

				M.-A. Bae, J.-E. Pie, and B. J. Song Acetaminophen Induces Apoptosis of C6 Glioma Cells by Activating the c-Jun NH2-Terminal Protein Kinase-Related Cell Death Pathway Mol. Pharmacol., October 1, 2001; 60(4): 847 - 856. [Abstract] [Full Text] [PDF]

				M. J. Beck, C. McLellan, R. L.-F. Lightle, M. A. Philbert, and C. Harris Spatial Glutathione and Cysteine Distribution and Chemical Modulation in the Early Organogenesis-Stage Rat Conceptus in Utero Toxicol. Sci., July 1, 2001; 62(1): 92 - 102. [Abstract] [Full Text] [PDF]

				E. Waters, J. H. Wang, H. P. Redmond, Q. D. Wu, E. Kay, and D. Bouchier-Hayes Role of taurine in preventing acetaminophen-induced hepatic injury in the rat Am J Physiol Gastrointest Liver Physiol, June 1, 2001; 280(6): G1274 - G1279. [Abstract] [Full Text] [PDF]

				H. Dong, R. L. Haining, K. E. Thummel, A. E. Rettie, and S. D. Nelson Involvement of Human Cytochrome P450 2D6 in the Bioactivation of Acetaminophen Drug Metab. Dispos., April 13, 2001; 28(12): 1397 - 1400. [Abstract] [Full Text]

				W. L. Trepicchio, M. Bozza, P. Bouchard, and A. J. Dorner Protective Effect of rhIL-11 in a Murine Model of Acetaminophen-Induced Hepatotoxicity Toxicol Pathol, February 1, 2001; 29(2): 242 - 249. [Abstract] [PDF]

				B. I. Ghanayem, Hongbing Wang, and S. Sumner Using Cytochrome P-450 Gene Knock-Out Mice to Study Chemical Metabolism, Toxicity, and Carcinogenicity Toxicol Pathol, November 1, 2000; 28(6): 839 - 850. [Abstract] [PDF]

				J. F. Mahler The Use of Genetically Altered Animals in Toxicology Toxicol Pathol, May 1, 2000; 28(3): 447 - 449. [PDF]

				F. P. Guengerich Metabolism of chemical carcinogens Carcinogenesis, March 1, 2000; 21(3): 345 - 351. [Abstract] [Full Text] [PDF]

				T. L. Horn, T. D. O'Brien, L. B. Schook, and M. S. Rutherford Acute Hepatotoxicant Exposure Induces TNFR-Mediated Hepatic Injury and Cytokine/Apoptotic Gene Expression Toxicol. Sci., March 1, 2000; 54(1): 262 - 273. [Abstract] [Full Text] [PDF]

				H. Kono, B. U. Bradford, M. Yin, K. K. Sulik, D. R. Koop, J. M. Peters, F. J. Gonzalez, T. McDonald, A. Dikalova, M. B. Kadiiska, et al. CYP2E1 is not involved in early alcohol-induced liver injury Am J Physiol Gastrointest Liver Physiol, December 1, 1999; 277(6): G1259 - G1267. [Abstract] [Full Text] [PDF]

				B. I. Ghanayem, J. M. Sanders, B. Chanas, L. T. Burka, and F. J. Gonzalez Role of Cytochrome P-450 2E1 in Methacrylonitrile Metabolism and Disposition J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1054 - 1059. [Abstract] [Full Text]

				J. Gu, Q.-Y. Zhang, M. B. Genter, T. W. Lipinskas, M. Negishi, D. W. Nebert, and X. Ding Purification and Characterization of Heterologously Expressed Mouse CYP2A5 and CYP2G1: Role in Metabolic Activation of Acetaminophen and 2,6-Dichlorobenzonitrile in Mouse Olfactory Mucosal Microsomes J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1287 - 1295. [Abstract] [Full Text]

				M. Pirmohamed, A. M Breckenridge, N. R Kitteringham, and B K. Park Fortnightly review: Adverse drug reactions BMJ, April 25, 1998; 316(7140): 1295 - 1298. [Full Text]

				K. J. Woodcroft and R. F. Novak Xenobiotic-Enhanced Expression of Cytochromes P450 2E1 and 2B in Primary Cultured Rat Hepatocytes Drug Metab. Dispos., April 1, 1998; 26(4): 372 - 378. [Abstract] [Full Text]

				J. L. Raucy, E. D. Schultz, M. R. Wester, S. Arora, D. E. Johnston, J. L. Omdahl, and S. P. Carpenter Human Lymphocyte Cytochrome P450 2E1, a Putative Marker for Alcohol-Mediated Changes in Hepatic Chlorzoxazone Activity Drug Metab. Dispos., December 1, 1997; 25(12): 1429 - 1435. [Abstract] [Full Text]

				Extended Abstracts Toxicol Pathol, November 1, 1997; 25(6): 674 - 696. [PDF]

				L. Zhou, R. R. Erickson, J. P. Hardwick, S. S. Park, S. A. Wrighton, and J. L. Holtzman Catalysis of the Cysteine Conjugation and Protein Binding of Acetaminophen by Microsomes from a Human Lymphoblast Line Transfected with the cDNAs of Various Forms of Human Cytochrome P450 J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 785 - 790. [Abstract] [Full Text]

				Y. Hu, M. Oscarson, I. Johansson, Q.-Y. Yue, M.-L. Dahl, M. Tabone, S. Arinco, E. Albano, and M. Ingelman-Sundberg Genetic Polymorphism of Human CYP2E1: Characterization of Two Variant Alleles Mol. Pharmacol., March 1, 1997; 51(3): 370 - 376. [Abstract] [Full Text] [PDF]